# Amerigen Pharmaceuticals Inc., Lyndhurst, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/amerigen-pharmaceuticals-inc/249d618c-b415-40b6-b86d-53c20e6e7db8

> Inspection records and compliance data for Amerigen Pharmaceuticals Inc. in Lyndhurst, New Jersey. 2 FDA inspections on record, 1 Form 483, last inspected January 18, 2019.

---

## Details

- Name: Amerigen Pharmaceuticals Inc.
- FEI Number: 3008849302
- Address Line 1: 9 Polito Ave Ste 900
- City: Lyndhurst
- State: New Jersey
- Zip Code: 07071
- Country Name: United States
- Address: 9 Polito Ave Ste 900, Lyndhurst, New Jersey 07071, United States
- Country: United States

## Related Documents

- [EIR - Amerigen Pharmaceuticals Inc. - 2019-01-18](https://www.keypedia.com/records/eir/amerigen-pharmaceuticals-inc/8da34b2d-f7a9-4c99-b54c-5bea030d9a8b) — source: FDA, date: January 18, 2019
- FDA Inspection 1077150 - Amerigen Pharmaceuticals Inc. - 2019-01-18 — classification: No Action Indicated (NAI), source: FDA, date: January 18, 2019
- [EIR - Amerigen Pharmaceuticals Inc. - 2017-07-27](https://www.keypedia.com/records/eir/amerigen-pharmaceuticals-inc/827f0b1f-40a6-4071-913b-bc6f408071b8) — source: FDA, date: July 27, 2017
- [483 - Amerigen Pharmaceuticals Inc. - 2017-07-27](https://www.keypedia.com/records/483/amerigen-pharmaceuticals-inc/0ac14809-47bb-4a47-b131-09b6e4feab39) — source: FDA, date: July 27, 2017
- [FDA Inspection 1019314 - Amerigen Pharmaceuticals Inc. - 2017-07-27](https://www.keypedia.com/records/fda_inspections/amerigen-pharmaceuticals-inc/871e5fa7-22b9-4005-9c90-2e8adfd939e6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 27, 2017
- FDA Inspection 1019314 - Amerigen Pharmaceuticals Inc. - 2017-07-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 27, 2017

## Related Companies

- [Ahsan A. Abdulghani, M.D.](https://www.keypedia.com/companies/ahsan-a-abdulghani-md/695f1bb9-8d1b-4f0c-b158-c5b387d4f232)
- [David R. Hassman, DO](https://www.keypedia.com/companies/david-r-hassman-do/9b4de0fb-3926-4c3e-93d4-3d0f2a2d8e9d)
- [Dipakkumar P. Pandya, M.D.](https://www.keypedia.com/companies/dipakkumar-p-pandya-md/631c758f-82bc-4c31-af74-60c256273243)
- [APCER Life Sciences, Inc.](https://www.keypedia.com/companies/apcer-life-sciences-inc/3afe0f1d-1b9a-43dc-8add-9648a712cd2e)
- [Cispharma Inc.](https://www.keypedia.com/companies/cispharma-inc/0d87b829-9561-45d1-a9c1-78adeea42dd6)
- [FOAMIX PHARMACEUTICALS, INC.](https://www.keypedia.com/companies/foamix-pharmaceuticals-inc/9912add0-b999-40e7-9fe5-60ded461ff2c)
- [Steven David, M.D.](https://www.keypedia.com/companies/steven-david-md/7ab4fd6d-3a02-41f4-b742-6e878e3df96d)
- [Dr. Reddy's Laboratories, Inc.](https://www.keypedia.com/companies/dr-reddys-laboratories-inc/bc9de265-3f90-4f32-ba51-6a3b16de3ffc)
- [Concordia Clinical Research (IRB)](https://www.keypedia.com/companies/concordia-clinical-research-irb/63b3f935-6298-417f-b3b5-59ab1f8d2f62)
- [Essex Institutional Review Board, Inc](https://www.keypedia.com/companies/essex-institutional-review-board-inc/7cb55d93-20ab-4c32-a3a4-5628657883eb)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/anastasia-offordile/299aed81-16f8-413e-a318-2d7f741957da)
- [recipient](https://www.keypedia.com/people/joanne-leonard/3f83bc85-32da-44fa-8fe7-e694c28a49ad)
- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)